Home CENSO BIOTECHNOLOGIES

CENSO BIOTECHNOLOGIES

EVOTEC EXPANDS IPSC DRUG DISCOVERY LEADERSHIP THROUGH STRATEGIC COLLABORATION WITH CENSO BIOTECHNOLOGIES

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a collaboration with Censo Biotechnologies Ltd. (“Censo”) to source and provide patient-derived induced pluripotent stem cells (“iPSC”) to support Evotec’s broad iPSC platform. Censo will provide its...